Copenhagen 2016 Registration Programme Exhibitor Information Virtual Exhibition Satellite Meetings Glaucoma Day 2016 Hotel Star Alliance

10 - 14 Sept. 2016, Bella Center, Copenhagen, Denmark

This Meeting has been awarded 27 CME credits


escrs app advert yo advert


Search Title by author or title

Visual outcomes following implantation of a trifocal lens

Poster Details

First Author: L. Paparo COLOMBIA

Co Author(s):                        

Abstract Details


To assess visual outcomes following bilateral implantation of a trifocal intraocular lens (IOL)


Cornea and Refractive Surgery Service, VISUALASER, Centro Medio Imbanaco. Cali, Colombia


This ongoing, prospective, single center study included 20 patients bilaterally implanted with the FineVision IOL (PhysIOL SA, Liège, Belgium) with a mean power of 20.20 ± 1.95. Cataract surgery was performed using a standardized suture-less technique. Monocular uncorrected and corrected visual acuities (VA) at near, intermediate and distance were assessed up to 6 months postoperative. Binocular defocus curve measurements were performed by recording best corrected visual acuity through lenses from -3.0 D to +4.0 D in 0.5 D steps.


The preoperative Visual acuities were: Uncorrected distance visual acuities (UCDVA):0.49 logMar, Best distance corrected visual acuities (BDCVA):0.08 logMar Data for the first 18 patients showed that at 4 months postoperative, mean monocular uncorrected VA (n=18) was 0.0878 ± 0.1072. Mean monocular uncorrected intermediate VA (IVA) was 0.2 ± 0.086 and mean monocular near VA (NVA) was 0.115 ± 0.1263. Mean monocular best distance corrected (BDC) VA was 0.0378 ± 0.0792, mean monocular BDCIVA was 0.1888 ± 0.079 and mean monocular BCDNVA was 0.0778 ± 0.083. Mean sphere was 0.0769 ± 0.270. The defocus curve showed that the IOL provided continuous range of vision.


The FineVision trifocal IOL demonstrated good visual acuity at near, intermediate and distance. Contrast sensitivity, quality of life data will be collected and reported at the 6 month postoperative visit.

Financial Disclosure:


Back to Poster listing